Browsing College of Health Sciences (CHS) by Author "Ocama, Ponsiano"
-
Ethical oversight of multinational collaborative research: lessons from Africa for building capacity and for policy
Sugarman, Jeremy; Ocama, Ponsiano (The Association of Research Ethics Committees, 2007)Researchers and others involved in the research enterprise from 12 African countries met with those working in ethics and oversight in the United States as part of an effort to develop research ethics capacity. Drawing on ... -
High burden of hepatitis B infection in Northern Uganda: results of a population-based survey.
Ochola, Emmanuel; Ocama, Ponsiano; Orach, Christopher G; Nankinga, Ziadah K; Kalyango, Joan N; McFarland, Wlli; Karamagi, Charles (BMC Public Health, 2013-08)Background: Worldwide 2 billion people are exposed to hepatitis B infection, 350 million have chronic infection, 65 million in sub-Saharan Africa. Uganda is highly endemic with 10% national prevalence of hepatitis B ... -
Is it safe to switch from stavudine to zidovudine after developing symptomatic hyperlactatemia?
Castelnuovo, Barbara; Nanyonjo, Agnes; Kamya, Moses; Ocama, Ponsiano (African Health Sciences, 2008-06)Introduction: In resource limited settings patients on antiretroviral treatment who develop stavudine induced hyperlactatemia are often switched to zidovudine on the basis of published studies that demonstrate that this ... -
The liver in HIV in Africa
Ocama, Ponsiano; Feld, Jordan J; Ronald, Allan (International Medical Press, 2005)As access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B ... -
The liver in HIV in Africa
Feld, Jordan J.; Ocama, Ponsiano; Ronald, Allan (International Medical Press, 2005)As access to antiretroviral therapy improves across the African continent, liver disease is emerging as an important cause of morbidity and mortality among HIV-infected individuals. Although coinfection with hepatitis B ... -
The spectrum of liver diseases in HIV infected individuals at an HIV treatment clinic in Kampala, Uganda
Ocama, Ponsiano; Katwere, Michael; Piloya, Theresa; Feld, Jordan; Opio, Kenneth C.; Katabira, Elly; Thomas, David; Colebunders, Robert; Ronald, Allan (Makerere University Medical School, 2008-03)Background: Liver diseases are common in patients with HIV due to viral hepatitis B and C co-infections, opportunistic infections or malignancies, antiretroviral drugs and drugs for opportunistic infections. Objective: To ... -
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a Resource-Limited Setting (Uganda).
Songa, Patricia Mwebaze; Castelnuovo, Barbara; Mugasha, Estella Birabwa; Ocama, Ponsiano; Kambugu, Andrew (University of Chicago Press, 2007)We describe 24 Ugandan patients with human immunodeficiency virus infection who developed symptomatic hyperlactatemia associated with the use of nucleoside analogues. All patients were receiving combination therapy that ... -
Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a Resource-Limited Setting (Uganda).
Songa, Patricia Mwebaze; Castelnuovo, Barbara; Mugasha, Estella Birabwa; Ocama, Ponsiano; Kambugu, Andrew (University of Chicago Press, 2007-08-15)We describe 24 Ugandan patients with human immunodeficiency virus infection who developed symptomatic hyperlactatemia associated with the use of nucleoside analogues. All patients were receiving combination therapy that ... -
Symtomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource limited setting (Uganda).
Songa, Patricia Mwebaze; Castelnuovo, Barbara; Mugasha, Estella Birabwa; Ocama, Ponsiano; Kambugu, Andrew (University of Chicago Press, 2007-04-19)We describe 24 Ugandan patients with human immunodeficiency virus infection who developed symptomatic hyperlactatemia associated with the use of nucleoside analogues. All patients were receiving combination therapy that ... -
A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the ‘2for1’ project.
Nankya‑Mutyoba, Joan; Ejalu, David; Wandera, Claude; Beyagira, Rachel; Amandu, Jacinto; Seremba, Emmanuel; Mugagga, Kaggwa; Kambugu, Andrew; Muganzi, Alex; Easterbrook, Philippa; Ocama, Ponsiano (BMC Medical Education, 2022)Introduction: The “2for1” project is a demonstration project to examine the feasibility and effectiveness of HBV care integrated into an HIV clinic and service. An initial phase in implementation of this project was the ... -
Treatment of chronic hepatitis B virus infection in resource-constrained settings: expert panel consensus
Wiersma, Steven T.; McMahon, Brian; Pawlotsky, Jean-Michel; Thio, Chloe L.; Thursz, Mark; Lim, Seng Gee; Ocama, Ponsiano; Esmat, Gamal; Maimuna, Mendy; Bell, David; Vitoria, Marco; Eramova, Irina; Lavanchy, Daniel; Dusheiko, Geoff (John Wiley & Sons, 2010)Most of the estimated 350 million people with chronic hepatitis B virus (HBV) infection live in resource-constrained settings. Up to 25% of those persons will die prematurely of hepatocellular carcinoma (HCC) or cirrhosis. ...